Advanced Biomed Inc. (ADVB) stock
ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
$2.53−0.78 (-23.56%)
Close on Nov 13, 2026Market cap $4.18MP/E 0.4Yield –
Advanced Biomed r&d expenses
Research and development expenses are spending on new products and technology.
Advanced Biomed's R&D Expenses for the twelve months ending Mar 31, 2026 was $975.26K, up 18.5% year over year. For fiscal 2025 it was $909.77K, up 3.4% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $909.77K | +3.4% |
| FY2024 | Jun 30, 2024 | $880.19K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $243.23K | +10.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $186.33K | -12.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $235.99K | +29.9% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $309.72K | +48.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $219.97K | -29.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $212.40K | +12.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $181.70K | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $209.11K | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $313.51K | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $188.39K | – |
See a number that looks wrong?